Using [68Ga]Ga-PSMA-11 PET/CT to monitor treatment response in prostate cancer patients can offer important lesion-based insights over prostate-specific membrane antigen (PSMA)-based monitoring, according to a new study published in EJNMMI Research.
“Like all aspects of medicine, it's important to make sure imaging is justified, and that the potential benefits are balanced against the potential harms," said lead author Rebecca Smith-Bindman, MD.
Researchers from the University of Oxford have created a new biomarker based off of coronary CT angiography (CCTA) images that can select patients at a high risk of heart attack five years before they occur.
Providing patients more testing choices does not increase their participation in colorectal cancer screening—but the way clinician’s framed those choices did, according to a new study published in JAMA Network Open.
The Department of Energy (DOE)’s National Nuclear Security Administration has issued a fourth, and final, cooperative agreement to Corvallis, Oregon-based Northwest Medical Isotopes, LLC.
The FDA released a statement, Thursday, Aug. 29, recommending duodenoscope manufacturers and health care facilities begin transitioning to new, innovate scopes that are less risky to patients.
A new radiomics-based machine learning model can evaluate immunohistochemistry (IHC) features and CT images to predict the presence of thyroid nodules, according to a new study published in the American Journal of Roentgenology.
Trenton T. Kellock, MD, with Royal Inland Hospital’s Department of Medical Imaging in British Columbia, Canada, and colleagues performed a systematic review and meta-analysis of studies including more than 1,200 patients.
At the congress, Philips is showcasing Release 5.0 of its EPIQ CVx cardiology platform for the first time in Europe. The platform includes automated applications for 2D assessment of the heart, as well as robust 3D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct.
